FLT3mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia-Reference-Cited by-同舟云学术

FLT3mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia

Published:2012-10-31 Issue:1 Volume:88 Page:56-59
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Daver Naval,Strati Paolo,Jabbour Elias,Kadia Tapan,Luthra Raja,Wang Sa,Patel Keyur,Ravandi Farhad,Cortes Jorge,Qin Dong Xiao,Kantarjian Hagop,Garcia-Manero Guillermo

Publisher

Wiley

Subject

Hematology

Reference31 articles.

1. Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: A concise review;Baldus;Br J Haematol,2007

2. FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model;Grundler;Blood,2005

3. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia;Nakao;Leuk: Off J Leuk Soc Am Leuk Res Fund UK,1996

4. Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia: Are we there yet?;Odenike;Semin Oncol,2011

5. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: Association with FAB subtypes and identification of subgroups with poor prognosis;Thiede;Blood,2002

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy;Critical Reviews in Oncology/Hematology;2024-09

2. Beyond HMAs: Novel targets and therapeutic approaches;Seminars in Hematology;2024-08

3. Recent Advances in the Molecular Pathogenesis and Diagnosis of Chronic Myelomonocytic Leukemia;Advances in Molecular Pathology;2024-08

4. Phase 1 study of azacitidine in combination with quizartinib in patients with FLT3 or CBL mutated MDS and MDS/MPN;Leukemia Research;2024-07

5. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee;Blood;2024-05-30